Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
American Journal of Hematology
|
July 1, 1992
Coagulation factor IX: successful surgical experience with a purified factor IX concentrate
J C Goldsmith, C K Kasper, P M Blatt, et al.
Seminars in Thrombosis and Hemostasis
|
May 14, 1998
PFA-100 system: a new method for assessment of platelet dysfunction
E F Mammen, P C Comp, R Gosselin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 20, 2017
Efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures
N Zozulya, C M Kessler, A Klukowska, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction
A L Goldstein, P H Naylor, R S Schulof, et al.
Circulation
|
June 1, 1990
Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation
B Brenner, C W Francis, S Totterman, et al.
Lancet (London, England)
|
August 6, 1988
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism
S Z Goldhaber, C M Kessler, J Heit, et al.
Lancet (London, England)
|
September 17, 1994
Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study
J J Goedert, A R Cohen, C M Kessler, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 26, 2012
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?
A C Spyropoulos, N A Goldenberg, C M Kessler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 13, 2016
Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A
M V Ragni, J G Yabes, P F Fogarty, et al.
British Journal of Haematology
|
October 1, 1984
Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A
C M Kessler, R S Schulof, O Alabaster, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
American Journal of Hematology
|
July 1, 1992
Coagulation factor IX: successful surgical experience with a purified factor IX concentrate
J C Goldsmith, C K Kasper, P M Blatt, et al.
Seminars in Thrombosis and Hemostasis
|
May 14, 1998
PFA-100 system: a new method for assessment of platelet dysfunction
E F Mammen, P C Comp, R Gosselin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 20, 2017
Efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures
N Zozulya, C M Kessler, A Klukowska, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction
A L Goldstein, P H Naylor, R S Schulof, et al.
Circulation
|
June 1, 1990
Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation
B Brenner, C W Francis, S Totterman, et al.
Lancet (London, England)
|
August 6, 1988
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism
S Z Goldhaber, C M Kessler, J Heit, et al.
Lancet (London, England)
|
September 17, 1994
Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study
J J Goedert, A R Cohen, C M Kessler, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 26, 2012
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?
A C Spyropoulos, N A Goldenberg, C M Kessler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 13, 2016
Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A
M V Ragni, J G Yabes, P F Fogarty, et al.
British Journal of Haematology
|
October 1, 1984
Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A
C M Kessler, R S Schulof, O Alabaster, et al.
Page
of 15